Fatimah Shepherd faced a dangerous medical decision. She had systemic lupus erythematosus, an autoimmune disease that damaged her kidneys. Pregnancy posed a serious risk. The condition could trigger kidney failure during gestation, potentially killing both her and her baby.
Lupus affects roughly 1.5 million Americans, with women accounting for 90 percent of cases. The disease causes the immune system to attack healthy tissues, including the kidneys, heart, and joints. Pregnancy complicates lupus management because hormonal changes intensify autoimmune activity. Studies show pregnant women with lupus face higher rates of miscarriage, preeclampsia, and premature delivery.
Shepherd's kidney function was already compromised before conception. Her nephrologist warned that the metabolic demands of pregnancy could overwhelm her failing organs. Yet she wanted children.
Doctors typically recommend lupus patients wait until their disease enters remission before attempting pregnancy. They also prescribe specific medications, like hydroxychloroquine and certain biologics, that suppress lupus activity while remaining safe during gestation. Close monitoring through obstetrics and nephrology teams becomes essential.
Shepherd ultimately made her choice after consulting specialists. Her case highlights the difficult reality facing women with serious autoimmune conditions. Modern medicine offers options, but pregnancy remains inherently risky when lupus has damaged vital organs.